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Regional Distribution of
Neurofibrillary Tangles and Senile
Plaques in the Cerebral Cortex of
Elderly Patients: A Quantitative
Evaluation of a One-Year Autopsy
Population from a Geriatric
Hospital
Detailed analyses of the neuropathologic changes in the
cerebral cortex of elderly individuals and Alzheimer's
disease patients have demonstrated that certain com-
ponents of the neocortical and hippocampal circuits are
likely to be selectively vulnerable. Based on the distri-
bution of neurofibrillary tangles (NFTs) and senile
plaques, it has been proposed that a global cortico-
cortical disconnection leads to the loss of integrated
functions observed in Alzheimer's disease. In order to
investigate the distribution of lesions associated with
aging as well as with the earliest symptoms of senile
dementia, we performed a quantitative neuropathologic
evaluation of a large series of elderly patients repre-
senting the entire autopsy population for the year 1989
from a geriatric hospital. Among the 145 cases quan-
titatively assessed, there were 102 nondemented pa-
tients, 33 patients presenting clinically with globally
intact intellectual function but early signs of impairment
of specific cognitive functions, and 10 cases with senile
dementia of the Alzheimer type. All of the cases had
NFTs in layer II of the entorhinal cortex, regardless of
their clinical diagnosis, and most cases had some NFTs
in the CA1 field of the hippocampus. Severe pathologic
changes within the inferior temporal neocortex were
observed only in the demented cases. The extent of
amyloid deposition was not correlated with the clinical
diagnosis and seemed to be present in the neocortical
areas earlier than in the hippocampal formation. Also,
several cases contained NFTs without amyloid depo-
sition, but amyloid never occurred without NFTs. These
results suggest that involvement of certain structures
within the hippocampal formation is a consistent feature
of aging. Thus, involvement of the hippocampal for-
mation may be a necessary, but not sufficient, condition
for the clinical expression of dementia, which is likely
to be more closely related to the progressive degen-
eration of select neuronal populations in the neocortex.
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Neurofibrillary tangles (NFTs), senile plaques (SPs),
and loss of large neurons are three pathological find-
ings commonly observed in the cerebral cortex of
Alzheimer's disease cases (Tomlinson et al., 1970;
Ball, 1977; Terry et al., 1981; Mountjoy et al., 1983).
The laminar and regional localization pattern of NFTs
and SPs within the cerebral cortex indicates that a
selective degeneration of long corticocortical and
hippocampal projection systems is likely to occur
(Mutrux, 1947; Pearson et al., 1985; Rogers and Mor-
rison, 1985; Hyman et al., 1986, 1988, 1990; Lewis et
al., 1987; Hof and Morrison, 1990; Hof et al., 1990a,b;
Arnold etal., 1991; Braak and Braak, 1991; De Lacoste
and White, 1993), leading to a disconnection of the
cerebral cortex and resulting in the disintegration of
intellectual functions observed in Alzheimer's dis-
ease patients (Pearson et al., 1985; Rogers and Mor-
rison, 1985; Hyman et al., 1986; Lewis et al., 1987; Hof
and Morrison, 1990; Hof et al., 1990a,b). In fact, Hy-
man and colleagues have demonstrated that the pres-
ence of NFTs in layer II of the entorhinal cortex was
correlated by the presence of pathologic profiles in
the termination zone of the perforant pathway in the
outer portion of the molecular layer of the dentate
gyrus, implying that this cortical pathway is severely
affected in Alzheimer's disease cases (Hyman et al.,
1988). In addition, the distribution of NFTs and SPs
in the neocortex and in the hippocampal formation
suggests that SP formation may involve the terminal
arborization of NFT-bearing neurons (Pearson et al.,
1985; Rogers and Morrison, 1985; Lewis et al., 1987;
Hof and Morrison, 1990; Hof et al., 1990a; Senut et
al., 1991; De Lacoste and White, 1993).
The distribution and density of these lesions in the
cerebral cortex have been correlated with the degree
of cognitive impairment in Alzheimer's disease. For
example, Tomlinson et al. (1970) have reported a
significant correlation between the mean SP frequen-
cy from several areas of the cerebral cortex and de-
mentia severity assessed within 6 weeks of death us-
ing the Blessed Dementia Scale. However, these
authors did not document the relationship between
cortical NFT formation and dementia severity in their
series. Other quantitative evaluations of the associa-
tion of SPs and NFTs with dementia severity in Al-
zheimer's disease demonstrated a substantially great-
er correlation of cortical NFT than SP density,
particularly in the temporal neocortex and parahip-
pocampal gyrus (Wilcock and Esiri, 1982; Arriagada
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et al., 1992a). In addition, the severity of dementia
has been shown to be highly correlated with synapse
loss in neocortical areas (Tern' et al., 1991).
The presence of Alzheimer's disease-related le-
sions in the brains of nondemented elderly individ-
uals is well established (Tomlinson et al., 1968; Da-
yan, 1970; Ball, 1977; Mountjoy et al., 1983; Ulrich,
1985). More recently, several studies have demon-
strated that amyloid deposition and NFT formation
not only are common features of brain aging, but are
found in certain regions of the cerebral cortex in den-
sities that would qualify for a neuropathologic diag-
nosis of Alzheimer's disease cases (Crystal et al., 1988;
Katzman et al., 1988; Hubbard et al., 1990; Morris et
al., 1991; Price et al., 1991; Arriagada et al., 1992a,b;
Hof et al., 1992; Berg et al., 1993; Bouras et al., 1993).
In particular, a careful analysis of such cases revealed
that in this population, the hippocampal formation
systematically displayed a moderate to severe involve-
ment, whereas the neocortical areas were unaffected
or showed very low densities of NFTs and SPs (Price
et al., 1991; Arriagada et al., 1992a; Hof et al., 1992;
Berg et al., 1993; Bouras et al., 1993). This difference
in regional lesion distribution distinguishes these el-
derly nondemented cases from the Alzheimer's dis-
ease population, in which neocortical areas are dev-
astated (Pearson et al., 1985; Lewis et al., 1987; Hof
et al., 1990a,b, 1992; Bouras et al., 1992). Most of the
recent clinicoanatomic analyses of brain aging have
been based on relatively small patient samples con-
sisting of selected cases (Crystal et al., 1988; Katzman
et al., 1988; Hubbard et al., 1990; Morris et al., 1991;
Price et al., 1991; Arriagada et al., 1992a,b; Hof et al.,
1992). In the present study, we had the opportunity
to survey all of the autopsied cases from a geriatric
hospital for the year 1989. We thus analyzed a large
number of nonselected cases from a nonpsychiatric
hospital in order to assess the degree to which elderly
patients are affected by Alzheimer's disease-related
neuropathologic changes, and to evaluate the age-
related factors leading to NFT formation and amyloid
deposition in a nondemented population. Part of this
study has been reported in abstract form (Bouras et
al., 1992).
Materials and Methods
Survey of Population
We surveyed the entire population of autopsy cases
from the Geriatric Hospital of the University of Ge-
neva School of Medicine (Switzerland) for the year
1989. This hospital is a large university-based insti-
tution (256 beds) that functions as the main geriatric
care center for the greater Geneva area (about 400,000
inhabitants). A total number of 176 cases, all older
than 65 years of age, were included in the present
study (Table 1). There were 77 men (81.2 ± 7.5 years
old; age range, 65-95; 43.75%) and 99 women (84.7
± 7.5 years old; age range, 66-101; 56.25%). Clinical
data on the patients were obtained from the medical
records of the Geriatric Hospital and from the Neu-
ropathological Database of the Division of Morpho-
logical Psychopathology, Department of Psychiatry,
University of Geneva School of Medicine, Geneva,
Switzerland. All cases were neuropsychologically
evaluated using a Mini-Mental State Examination
(Folstein et al., 1975). Although the vast majority of
the patients were hospitalized for terminal illness, all
had been tested neuropsychologically at least 4 months
prior to death. However, in some demented cases
presenting with terminal somatic illnesses (i.e., met-
astatic tumor, severe cardiac and/or renal insufficien-
cy) as well as in a few cases with Wernicke-Korsakoff
encephalopathy, neuropsychological evaluation was
no longer tenable. These cases (other dementia cases,
n = 28) were subsequently excluded from the ana-
tomoclinical correlations, although they were used in
the general neuropathological evaluation. In addi-
tion, three cases were also excluded from the analysis
because it was impossible to assess their mental and
cognitive function at admission (one oligophrenic
man, 85 years old, and two women presenting with
severe aphasia due to extensive vascular lesions, 87
and 89 years old, respectively). Thus, for anatomo-
clinical correlations, 145 cases (60 men, 79.6 ± 8.2
years old, age range 65-95, and 85 women, 83.3 ±
7.5 years old, age range 66-101) were considered and
were subdivided into three diagnosis groups accord-
ing to clinical and neuropathological findings (Table
1). Nondemented patients (ND cases, n = 102) pre-
sented with preserved intellectual functions and
showed no sign of temporospatial disorientation and
memory impairment. Demented patients exhibited a
greater variability in the clinical presentation. For in-
stance, some cases presented with severe disorien-
tation and memory impairment (DMI cases, n = 33),
but without aphasia-apraxia-agnosia syndrome. Other
cases exhibited clinically the typical symptomatology
of degenerative dementia of the Alzheimer type (AD
cases, n = 10), with marked temporospatial disori-
entation and cognitive impairment, aphasia, apraxia
and agnosia, and severe handicap in daily living. Al-
zheimer's disease was subsequently confirmed neu-
ropathologically in all cases from this group. Finally,
a large number of cases of all three diagnosis group
displayed variable degrees of vascular damage (n =
107). This finding is not uncommon in the brain of
elderly patients, and a recent neuropathologic study
of 50 demented cases has revealed that up to 30% of
the cases suffered from mixed dementia (Fallet-Bian-
co et al., 1990).
A full routine neuropathological evaluation of all
the cases was performed on selected cortical areas
(superior frontal, inferior temporal, inferior parietal,
primary and secondary visual cortex, and anterior hip-
pocampal formation). The densities and severity of
neuropathological changes (i.e., NFTs, amyloid de-
position, gliosis, microinfarcts, cortical atrophy) were
assessed for each area separately and filed in a custom
database. The total number of NFTs and amyloid-pos-
itive profiles was assessed from a series of random 1
mm2 cortical samples in all of the cortical areas sur-
veyed, for each case separately. For this purpose, am-
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Table 1
Distribution of the diagnosis groups
Diag-
nosis
Age
|±SD|
Sex
|M/W|
Fre-
quency
ND
DMI
AD
Other
81.3 ± 7.8
83.1 ± 7.4
88.6 ± 4.8
87.8 ± 5.1
43/59
17/16
0/10
16/12
102
33
10
28
59.0
19.0
5.8
16.2
NO, nondememed; DMI, disorientation and memory impairment; AD, degenerative
dementia of the Alzheimer type; Other, other dementia (refers to demented cases of
various etiology). A total number of 145 patients were considered. Due to incomplete
clinical data, a total of 31 cases were excluded from the analysis (the other dementia
group and three additional cases; see Materials and Methods). M/W, men/women.
yloid-positive profiles were not differentiated into
morphologic subgroups, and diffuse deposits, clas-
sical and core plaques were considered together for
the assessment of amyloid deposition within the se-
lected cortical regions. Depending on the density of
lesions, cases were subsequently subdivided for neu-
ropathologic assessment into four groups displaying
an absence of lesions, rare lesions (<1O NFTs or am-
yloid-positive profiles per mm2), moderate densities
of lesions (10-20 NFTs or amyloid-positive profiles
per mm2), or frequent lesions (>20 NFTs or amyloid-
positive profiles per mm2), respectively. All of the
cases with a clinical history of dementia were rated
as having frequent lesions in all of the cortical areas
surveyed, with lesion densities compatible with those
recommended by the CERAD guidelines (Mirra et al.,
1991, 1993). Additional tissues were available for de-
tailed analysis and immunohistochemistry.
Tissue Collection and Staining Procedure
All the brains were collected at autopsy (postmortem
delay, 2-24 hr), fixed, and subsequently stored in a
large volume of 10% formalin solution. For routine
neuropathological evaluation 20-^mthick section
were prepared from the selected areas (see above)
and were stained with modified Globus (Globus, 1927;
Hof et al., 1990a) and Gallyas (Gallyas, 1971; Hof et
al., 1990a) silver impregnation techniques, Luxol-fast
blue-Van Gieson, cresyl violet, and hematoxylin-eo-
sin. In addition, a modified thiofiavine S method was
used for routine semiquantitative neuropathologic as-
sessment (Guntern et al., 1992). This method yields
results comparable to those obtained on tissues stained
with antibodies to the microtubule-associated protein
tau or to the amyloid 0A4 protein (Vallet et al., 1992).
Briefly, 20-^m-thick sections were mounted onto poly-
L-lysine-coated slides. Then, they were treated with
0.25% KMnO, in PBS for 4 min. The sections were
then placed in a solution consisting of 1% K,S2O, and
1% oxalic acid in PBS for 2-3 min, rinsed, and stained
with 0.0125% thiofiavine S in 40:60 100% ethanol:PBS
(v/v ratio) for 3 min. They were finally differentiated
in 50% ethanol in PBS and coverslipped with glycerin:
H2O (3:1). With this method, lesions can be easily
identified under fluorescence lighting conditions us-
ing a Zeiss narrow-bandpass fiuorescein filter set. For
immunohistochemistry, additional sections were pro-
cessed with a specific antibodies to the microtubule-
associated protein tau and to the amyloid /3A4 protein.
Characterization and specificity of these antibodies
have been fully reported elsewhere (Defossez et al.,
1988; Kim et al., 1988; Delacourte et al., 1990). Briefly,
20-^m-thick sections were incubated overnight with
either the anti-tau antibody or the anti-/3A4 antibody,
both at a dilution of 1:4000. Following incubation,
sections were processed by the PAP method using
diaminobenzidine as a chromogen.
Quantitative Analysis
NFTs and SPs were counted on a series of nine sec-
tions stained with thiofiavine S (sections 1,4, 7), anti-
tau antibody (sections 2, 5, 8), and anti-|8A4 antibody
(sections 3, 6, 9). In the present study, quantitative
analysis was performed only on sections from the an-
terior hippocampus, entorhinal, rostral half of inferior
temporal cortex (Brodmann area 20), superior frontal
cortex (Brodmann area 9), and primary and secondary
visual cortex (Brodmann areas 17 and 18). For quan-
titative purposes, only classical and core plaques were
counted and referred to as SPs. Lesion densities were
assessed by two independent investigators (C.B.,
P.R.H.), with very high interrater reliability (>95%).
In all of the cases, NFT and SP densities were cal-
culated per mm2 within each cortical layer for each
selected area (five laminar measurements per sam-
ple). All quantitative analyses were performed on a
computer-assisted microscopy system consisting of a
Zeiss Axioplan photomicroscope equipped with a
motorized stage, high-sensitivity video camera (LH-
4036 LHESA Electronics), a Compaq Deskpro 386/20
microcomputer, and an SAMBA 2005 software devel-
oped by TITN Inc. (ALCATEL; Grenoble, France). Sta-
tistical analysis was performed using analysis of vari-
ance to compare distribution of lesions (NFTs, SPs)
in the different diagnosis groups. Correlations be-
tween presence of lesions, age, and severity of the
disease were calculated for the different cortical
regions.
Results
Regional Patterns of NFT and SP Distribution
In all of the 10 cases presenting with a clinical symp-
tomatology of dementia and with neuropathologically
confirmed Alzheimer's disease, NFT and SP distri-
butions were comparable to previous descriptions in
all the areas investigated (Pearson et al., 1985; Rogers
and Morrison, 1985; Lewis et al., 1987; Hof et al.,
1990a; Arnold et al., 1991; Braak and Braak, 1991).
For instance, NFTs were widespread in the hippo-
campal formation and predominated in the CA1 field,
subiculum, and layers II and V of the entorhinal cor-
tex. In the neocortex, NFTs were present in both lay-
ers III and V (Figs. 1, 2B,D), and were more numerous
in the inferior temporal cortex than in the superior
frontal, inferior parietal, and occipital cortex. SPs were
present in high densities in all cortical areas and were
preferentially located in the supragranular layers
within the neocortical regions. Furthermore, there
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Table 2
Incidence of lesions in the different diagnosis groups
ND OMI AD Other
NFT
Absent
Present
SP
Absent
Present
0(0)
102(100)
59 (57.8)
43 (42.2)
33|100)
11(34.4)
21 (65.6)
10(100)
1110.0]
9(90.0]
0(0)
28(1001
7 (25.0)
21 (75.0)
Results represent the total number of patients [n = 176] with presence or absence of NFTs, SPs, and vascular involvement in each diagnosis group. Percentages of cases within
each diagnosis group are indicated in parentheses.
was no noticeable difference in SP distribution and
density between the inferior temporal and superior
frontal cortex (Fig. 2/4, C). The visual areas of the
occipital cortex had relatively high SP densities pre-
dominating in layer III and IV of the primary visual
cortex and in layer III of the secondary visual cortex.
Only rare NFTs were encountered in layer III of the
secondary visual cortex in the AD cases. Also, the
presence of NFTs and SPs was not related to the oc-
currence of alcoholism, smoking, or intercurrent so-
matic disorders in our population. Men were affected
as frequently as women, with the exception of the AD
group, which comprised only women, although this
difference may be due to the small size of this par-
ticular diagnosis category (n = 10).
In the cases presenting with disorientation and
mild cognitive impairment (DMI) as well as in the
nondemented cases (ND), the general distribution of
NFTs and SPs was qualitatively similar to that ob-
served in the demented (AD) cases; however, large
differences in lesion density were seen in all cortical
regions in both groups. In all these cases, NFTs were
systematically present in layer II of the entorhinal
cortex (Fig. 1A-C, Table 2). In this respect, it is worth
noting that in some cases of the ND group, NFTs were
observed exclusively in this layer and that the re-
mainder of the hippocampal and neocortical fields
were devoid of NFTs. In the CA1 field and in the
subiculum, NFTs were observed in variable densities
in the ND and DMI groups. In both ND and DMI
cases, NFTs were rare in the neocortical areas and,
when present, were preferentially distributed in layer
III of the inferior temporal cortex (Fig. 1D-F). Very
low numbers of NFTs were encountered in the su-
perior frontal cortex of these cases. It should be noted
that the inferior parietal cortex also contained very
low NFT densities in these cases, although no quan-
titative assessment was made in this region. In both
groups, SPs were present in highly variable densities
in all cortical regions (Fig. 2A,C), and were more
frequently observed in the inferior temporal cortex.
Numerous cases (57.8% of the ND cases, 34.4% of the
DMI cases, and 10.0% of the AD cases; Table 2) were
devoid of amyloid deposition. It should also be noted
that in some cases with NFT restricted to the entor-
hinal cortex, a high density of amyloid deposition in
the neocortex was observed in absence of clinical
symptomatology (Fig. 2A,C). In addition, there was
no difference in lesion densities between men and
women, and there was a correlation between age and
the presence of NFT (r = 0.70, p < 0.005), whereas
such a correlation was not observed for SP (Table 3).
Quantitative Analysis
A laminar and regional quantitative assessment of the
number of NFT in the different regions of the hip-
pocampal formation and neocortex revealed striking
differences between the diagnosis groups. In the hip-
pocampal formation, the entorhinal cortex had the
most severe involvement in all three diagnosis groups.
The ND group had NFT densities of 7.4 ± 0.8 per
mm2 in layer II, and 5.4 ± 1.2 in layer V. These values
were 21.0 ± 2.5 and 6.9 ± 3.2 in the DMI group, and
59.1 ± 12.4 and 31.7 ± 5.8 in the AD group, respec-
tively. The CA1 field of the hippocampus showed
slightly lower NFT densities as compared to the en-
torhinal cortex with values of 5.3 ±1.2 (ND), 13.3 ±
2.1 (DMI), and 87.5 ± 20.1 (AD) NFTs per mm2. The
subiculum had NFT counts comparable to those ob-
served in the CA1 (6.9 ± 1.3 in the ND cases, 11.7 ±
2.2 in the DMI cases, and 38.7 ± 8.7 in the AD cases).
In the neocortex, most of the NFT were localized in
the temporal areas and tended to be concentrated in
layer III (Figs. 1, 2). In all our cases, the frontal cortex
Table 3
Distribution of pathological changes in 176 patients < 6 5 years of age
Men Women
NFT
Absent
Rare
Frequent
SP
Absent
Rare
Frequent
Age
67.0
81.4
78.7
80.0
83.1
Total
0
1
75
32
1
43
%
0.0
1.3
98.7
42.1
1.3
56.6
Age
66.0
84.9
83.0
81.4
85.3
Total
0
2
98
27
5
68
%
0.0
2.0
98.0
27.0
5.0
68.0
NFTs and SPs were detected in the hippocampal formation and inferior temporal cortex
using specific antibodies to tau protein and /3A4 protein. Density of NFTs and SPs
was considered rare when < 1 0 lesions per slide, and frequent when > 2 0 lesions
per slide were counted. This patient population represent the total number of autopsy
cases from the University of Geneva Geriatric Hospital for the year 1989 (see Materials
and Methods for details). In both sex groups, the mean age, the total number, and
the percentage of cases presenting with a given severity of pathological changes are
indicated.
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contained fewer NFT than the temporal regions. Thus,
the inferior temporal cortex had NFT densities of 6.2
± 1.2 in layer III and 4.3 ± 0.8 in layer V (ND cases),
12.1 ± 1.9 and 7.8 ±1.5 (DMI cases), and 46.9 ± 6.5
and 25.3 ± 7.8 (AD cases). In the superior frontal
cortex these combined values for layers III and V were
4.9 ± 0.5, 5.6 ± 1.0, and 7.7 ± 3.3 in the ND, DMI,
and AD groups, respectively. Finally, NFT densities
in layer II of the entorhinal cortex and CA1 were
statistically correlated with the presence of disori-
entation and mild cognitive impairment (p < 0.001),
and Alzheimer's disease was further correlated with
the involvement of layer III of the inferior temporal
cortex (p < 0.005).
SPs were observed in all three diagnosis groups
and were more numerous in the demented patients.
The ND cases displayed generally fewer SP than the
cases from the two other groups. In addition, the neo-
cortex contained more SPs than the hippocampal for-
mation in all the cases. For instance, the inferior tem-
poral cortex had SP densities of 6.1 ± 0.9, 14.6 ± 2.1,
and 13.9 ± 3.4 per mm2 in layer III of the ND, DMI,
and AD cases, respectively, and 4.4 ± 0.7, 10.5 ± 1.6,
and 7.9 ± 2.5, respectively, in layer V. The superior
frontal cortex showed SP counts of 4.7 ± 0.6, 5.8 ±
0.9, and 12.9 ± 3.3 in layers III and V of the three
groups, respectively. These values were 8.6 ± 2.7, 7.8
± 1.1, and 19-6 ± 7.1, respectively, in layers III and
IV of the primary visual cortex, and 9.7 ± 2.9, 7.2 ±
0.9, and 17.6 ± 6.5, respectively, in layers III and V
of the secondary visual cortex. In the hippocampal
formation, the CA1 field contained the highest SP
densities, with values reaching 0.2 ± 0.1 in the ND
cases, 5.7 ± 1.1 in the DMI cases, and 10.0 ± 1.0 in
the AD cases. The subiculum contained 0.2 ± 0.1, 3.2
± 1.8, and 3.8 ± 0.8 SPs per mm2, respectively. In the
entorhinal cortex, the superficial layers displayed SP
densities of 0.6 ± 0.3, 7.2 ± 1.4, and 8.0 ± 1.7, re-
spectively, while in the deep layers, these values were
0.6 ± 0.3,5.3 ± 1.1, and 6.5 ± 0.6. Thus, the presence
of amyloid deposition was related to the clinical di-
agnosis of dementia in neocortical regions; however,
no difference could be found between the DMI and
AD groups. Also, it should be mentioned that despite
the relationship between the occurrence of amyloid
and dementia, there were cases devoid of amyloid
deposition in all three patient groups, as well as ND
cases displaying high numbers of SPs in the neocor-
tex.
Relationship between Presence qfNFTs and SPs
It should be mentioned that although NFTs were al-
ways visualized within layer II of the entorhinal cortex
in all cases, they were not necessarily present in all
cortical regions in any given case. For instance, de-
pending on the cortical area, up to 87% of the cases
presented without NFTs and 81% without SPs in at
least one cortical region in the ND group, while these
values were 79% and 51%, respectively, in the DMI
cases, and 70% and 30% in the AD cases (Table 4).
Also, it is worth noting that some ND cases with NFTs
mostlv restricted to laver II of the entorhinal cortex
and CA1 field contained large amounts of amyloid
deposition throughout the cerebral cortex (Fig. 2A-
D). However, no case had amyloid deposition with-
out NFTs, except in the visual areas of the occipital
cortex, which were basically devoid of NFTs and had
a relatively high density of SPs in all of the cases
(Table 4). Moreover, several cases (31.4% of ND cases,
12.5% of DMI cases, no AD cases) presented with
moderate-to-high NFT densities but were devoid of
amyloid deposition. A regional analysis of the coex-
istence of NFT and amyloid deposition (including
diffuse preamyloid deposits, classical and core
plaques) revealed that 26.4% of all cases had NFT in
layer III of the inferior temporal cortex without am-
yloid deposition in this region. Similarly, 590% of all
cases had NFTs in layer II of the entorhinal cortex,
and 39.8% in the CA1 field of the hippocampus in
absence of colocalized amyloid deposition. In addi-
tion, 45.0% of the cases displayed NFTs in the entor-
hinal cortex in absence of amyloid in the temporal
cortex, whereas 36.6% had NFTs in the CA1 and no
amyloid in the entorhinal cortex. Finally, 68.0% of the
cases had NFTs in layer II of the entorhinal cortex
and no amyloid in the CA1 field, and 25.3% showed
NFTs in the inferior temporal cortex and no amyloid
in the superior frontal cortex. These observations in-
dicate that there is a minimal correlation between the
presence of these two lesions in anatomically related
areas. However, there was a clear correlation between
NFT counts in regions or cortical layers that are an-
atomically linked. Thus, a strong correlation was ob-
served between NFT densities in layer II of the en-
torhinal cortex and in the CA1 field (r = 0.87, p <
0.001), in the subiculum and layer V of the entorhinal
cortex (r = 0.75, p < 0.001), and in layer V of the
entorhinal cortex and layer III of the inferior temporal
cortex (r = 0.84, p < 0.001).
Discussion
The present neuropathologic analysis of 176 elderly
individuals reveals that many features observed in the
brains of patients presenting with Alzheimer's disease
can also be found in a geriatric population, although
the severity of the changes is not as dramatic as in
Alzheimer's disease, and the distribution of patho-
logic profile is quite different (Bouras et al., 1992).
In particular, it is relevant to note that allot the cases
in our study demonstrated NFTs in layer II of the
entorhinal cortex, although 102 of these cases showed
no signs of cognitive and memory impairment at death.
Similarly, 57% of the ND cases had a few NFTs in the
CA1 field of the hippocampus, and 78% in the inferior
temporal cortex. SPs were not always observed and
although they tended to be more numerous in the
demented cases, there were clinically demented cases
containing only a few SPs. However, the NFT distri-
bution pattern suggests that the entorhinal cortex is
affected first, followed by the CA1 field, the subicu-
lum, the inferior temporal cortex, and finally other
neocortical regions. Conversely, as recently pointed
out by Arriagada and colleagues, we observed that
amyloid deposition appears to occur first in neocortex
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rather than in the hippocampal formation (Arriagada
et al., 1992b; Bouras et al., 1992), regardless of the
diagnosis group. However, when present in the neo-
cortex of ND cases, SP counts were within the range
of SP densities observed in the AD cases. Also, the
superior frontal cortex displayed relatively low den-
sities of NFTs and SPs and was involved more severely
only in the AD group.
These data suggest that some of the DM I and ND
cases may represent very early stages of Alzheimer's
disease, in that the inferior temporal cortex in these
cases might represent an interface between substan-
tially affected and unaffected areas, indicating that this
area may be a reliable landmark to study the rela-
tionships between the clinical observations and
pathologic findings. In particular, it emerges from our
analysis that even moderate-to-severe involvement of
the entorhinal cortex and CA1 field of the hippocam-
pus can be considered compatible with an apparently
normal cognitive status or a mild cognitive impair-
ment and disorientation that still allows for indepen-
dent daily living. However, once the degenerative
changes involve the neocortex, clinical signs of de-
mentia are observed, regardless of the age of the pa-
tients. This suggests that at all ages within a popu-
lation of elderly individuals, the implication of
neocortical areas is a necessary factor for the clinical
expression of the dementia. Although the vast major-
ity of our cases clearly were not demented, the slight
cognitive disturbances noted in the DMI cases are
similar to the early impairments seen in patients who
may subsequently progress to the global cognitive
and behavioral disturbances that characterize Alzhei-
mer's disease. Thus, the subtle cognitive disturbances
evidenced in some ND and DMI cases are associated
with a pattern of lesion distribution in the hippocam-
pal formation that is qualitatively compatible with a
neuropathological diagnosis of Alzheimer's disease.
However, the neuropathological involvement of the
neocortex differed dramatically from that of Alzhei-
mer's disease patients, given that there were few NFTs
outside of the hippocampal formation. This suggests
that extensive cortical SP and NFT formation restrict-
ed to medial temporal areas may take place long be-
fore the emergence of overt clinical symptoms of de-
mentia. Moreover, the relative preservation of global
cognitive functioning in the ND and DMI patients
might be related to the absence of widespread neo-
cortical NFT formation. In this context, it is worth
noting that in experimental models of memory im-
pairment, macaque monkeys with lesions restricted
to the hippocampus and amygdala displayed a sparing
of their learning skills, whereas lesions of the peri-
rhinal and parahippocampal fields TF and TH pro-
duced severe memory disturbances, stressing the fact
that these cortical fields are key elements of the mem-
ory system (Zola-Morgan and Squire, 1984; Zola-Mor-
gan et al., 1989; Squire and Zola-Morgan, 1991; Suzuki
et al., 1993).
The present results parallel previous observation
of Alzheimer's disease-related pathologic changes in
the brain of old patients with no signs of neurologic
Table 4
Percentages of cases presenting with NFTs and SPs in the three diagnosis groups
ND DMI AD
CA1
NFT
SP
Subiculum
NFT
SP
Entorhinal cortex
NFT
SP
Inferior temporal cortex
NFT
SP
Superior frontal cortex
NFT
SP
Primary visual cortex
NFT
SP
Secondary visual cortex
NFT
SP
57
19
56
28
100
30
78
42
13
44
0
83
0
75
73
49
64
49
100
50
84
66
21
61
0
100
0
100
100
70
100
70
100
70
90
90
30
90
0
100
1
100
Results represent the percentages of cases in each diagnosis group presenting with
NFTs and SPs. Note that layer II ol the entorhinal cortex is involved with NFT formation
in 100% of the cases. These results reflect only the occurrence ol lesions in the three
patient groups and therefore have a limited value in terms of correlation with severity
of dementia (see Results for details).
or psychiatric disorders (Tomlinson et al., 1968; Da-
yan, 1970; Terry et al., 1981; Mountjoy et al., 1983;
Ulrich, 1985; Crystal et al., 1988; Katzman et al., 1988;
Hubbard et al., 1990; Mann et al., 1990; Morris et al.,
1991; Price et al., 1991; Arriagada et al., 1992a,b; Hof
et al., 1992; Lippa et al., 1992; Vickers et al., 1992;
Berg et al., 1993; Bouras et al., 1993). For example,
Hubbard et al. (1990) reported a neuropathological
survey of 70 unselected cases from a general hospital.
In this series, four cases with documented evidence
of cognitive impairment showed numerous NFTs in
all neocortical areas examined, whereas six cases
showing no signs of cognitive decline had excessive
NFT formation confined to the hippocampal forma-
tion and temporal neocortex, but no NFTs in the other
neocortical regions. These authors suggest that NFT
formation confined to these areas may represent a
preclinical stage of Alzheimer's disease. Similarly, the
recent analysis of clinically assessed demented and
nondemented cases by Berg et al. (1993) demonstrat-
ed that NFT formation was a strong correlate of du-
ration and severity of dementia. In addition, this study
shows that only neocortical, but not hippocampal,
NFT densities represent a reliable index of dementia
(Berg et al., 1993), suggesting that involvement of
cortical structures outside of the hippocampal for-
mation is a prerequisite for the development of de-
mentia. Also, it indicates that the dementing syn-
drome may progress in the neocortex in presence of
relatively high and stable NFT densities in the hip-
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pocampus and entorhinal cortex (Berg et al., 1993;
Bierer et al., 1993).
Furthermore, a retrospective neuropathological as-
sessment of 12 cases aged over 100 years but without
clinically documented evidence of cognitive impair-
ment revealed dense NFTs in the CA1 field, moderate
NFT involvement in temporal cortex, and absence of
NFTs in other neocortical areas (Hauw et al., 1986).
These elderly nondemented cases demonstrate NFT
distribution quite similar to our ND cases, at least in
the hippocampus proper. Results from our laboratory
also demonstrate the preferential localization of NFT
in the CA1 field of nondemented centenarians, sug-
gesting that the distribution of lesions in these very
old unaffected patients may be somewhat different as
compared to nondemented younger cases, in that the
entorhinal cortex is less involved in centenarians
(Giannakopoulos et al., 1993). Thus, the distribution
of neuropathologic changes in aging may be more
complex than is usually thought, in that there may be
subgroups of patients with specific neuropsycholog-
ical profile that may correspond to the involvement
of select regions, connections, and neuron popula-
tions. Similar observations have been made by Braak
and Braak (1990) in six patients with NFTs predom-
inating in the entorhinal cortex, lower NFT counts in
the CA1 and temporal neocortex, and numerous SPs
in the temporal neocortex. These patients had a clin-
ical diagnosis of probable senile dementia but insuf-
ficient cortical SP and NFT densities to meet neuro-
pathologic criteria for the diagnosis of Alzheimer's
disease. Although these authors did not report a quan-
titative analysis of their cases, the distribution pattern
of the lesions is comparable to that observed in the
present series.
Other recent studies have shown that the clinical
dementia in Alzheimer's disease is associated with
the presence of neocortical NFTs, but that SPs may
be widespread in the cerebral cortex in the absence
of symptoms of cognitive and memory decline. For
instance, Katzman et al. (1988) described a series of
cases clinically considered nondemented, with cor-
tical SP distribution comparable to clinically and neu-
ropathologically confirmed Alzheimer's disease cases,
but with the absence of frontal and parietal NFT for-
mation. NFT formation in the temporal neocortex and
hippocampus of these cases was comparable to a con-
trol case series with minimal SP formation. Crystal et
al. (1988) reported a small series of prospectively
assessed elderly persons with cortical SP densities
similar to Alzheimer's disease cases, but rare cortical
NFTs, and ratings of cognitive function that did not
warrant a diagnosis of dementia. These cases are also
comparable to our ND and DMI cases since they
showed mild to severe NFT densities and relatively
low SP counts in the hippocampal formation. Four
other cases with anterogradely assessed Clinical De-
mentia Rating (CDR) scale scores of 0.5 (question-
able dementia), with SP formation throughout the
neocortex and NFTs confined to the hippocampal for-
mation have recently been described (Morris et al.,
1991). Similarly, we recently reported the case of a
nondemented patient demonstrating globally intact
intellectual function and initial symptoms of impaired
cognitive functions 2 weeks before death (Hof et al.,
1992). In this case, we found SP densities comparable
to those obtained in Alzheimer's disease cases in neo-
cortical areas, while high densities of NFTs were re-
stricted to select areas of the medial and inferior tem-
poral cortex, including hippocampus, entorhinal
cortex, perirhinal and inferior temporal cortex (Hof
et al., 1992). In a series of 25 patients prospectively
or retrospectively evaluated for dementia, Price et al.
(1991) demonstrated comparable densities and dis-
tribution of NFTs and SPs in 19 cases with CDR ratings
of 0.5-1.0, indicating minimal cognitive decline. Sim-
ilarly, an analysis of the hippocampal formation and
inferior temporal cortex in 6l nondemented elderly
cases revealed that in each region the number of neu-
rons affected by NFT formation, calculated from the
total number of neurons, gradually increased with age
and that eight of these cases consistently exhibited
higher NFT counts in all of the areas investigated than
the remainder of the patients (Bouras et al., 1993).
In this series, no correlation between SP counts and
NFT densities and age was observed (Bouras et al.,
1993). Dickson et al. (1991) showed that cortical am-
yloid deposition can be used to subdivide two neu-
ropathologic groups of elderly individuals character-
ized by either minimal or severe amyloid deposition.
However, these authors found no correlation between
amyloid deposition and the cognitive performance of
the patients (Dickson et al., 1991) and suggested that
other factors such as cytoskeletal alterations are nec-
essary for the development of dementia. All of these
data suggest that widespread cortical amyloid depo-
sition and NFT formation limited to certain hippo-
campal areas are not incompatible with intact cog-
nitive abilities, yet extensive NFT formation in
neocortex is clearly linked to cognitive decline.
The quantitative analysis of lesion distribution in
the cerebral cortex of many elderly cases suggests that
certain areas of the medial and inferior aspects of the
temporal lobe are likely to represent an early site of
NFT formation. In fact, NFT counts in the entorhinal
cortex of such cases are elevated even in comparison
to Alzheimer's disease cases with several years of evo-
lution. In addition, biochemical studies have dem-
onstrated the presence of abnormally phosphorylated
forms of the tau protein in the entorhinal cortex of
nondemented elderly persons, revealing the exis-
tence in this particular area of a biochemical dys-
function that is widespread in the cerebral cortex of
Alzheimer's disease cases (Vermersch et al., 1992).
The inferior temporal cortex, a visual association area,
appears to be an early transition zone between the
severely affected entorhinal and perirhinal cortex and
the mid temporal gyrus in these cases (Hof et al.,
1992). Thus, a progression in NFT density within ad-
jacent cortical components of the medial and inferior
aspects of the temporal cortex may be a neuropath-
ological hallmark of incipient dementia in elderly
patients presenting with normal cognitive abilities or
very mild cognitive impairment. It should be kept in
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mind that, in absence of a extensive quantitative in-
vestigation of the cerebral cortex, it is still possible
that there may be significant numbers of NFTs in cor-
tical areas not examined in the present survey. In this
context, the distribution of lesions in cortical regions
related to the limbic system is of particular interest.
A recent study has demonstrated that in Alzheimer's
disease, NFTs are predominantly distributed within a
restricted portion of the agranular orbitofrontal cortex
(Chu et al., 1993). The involvement of such regions
early in the progression of dementia could also ac-
count for some of the memory and behavioral distur-
bances presented by Alzheimer's disease patients.
However, our comprehensive quantitative study of a
nondemented individual with minimal signs of cog-
nitive impairment revealed that the orbitofrontal, cin-
gulate, as well as frontal, parietal, and mid and su-
perior temporal cortex was essentially devoid of NFTs,
suggesting that these areas may be affected at a later
stage in the progression of the disease (Hof et al.,
1992).
The fact that there is a strong correlation between
NFT densities in anatomically related cortical regions
is of special interest, since it has been proposed that
Alzheimer's disease involves certain conical circuits,
in particular, systems related to memory within the
hippocampal formation (Hyman et al., 1986, 1988,
1990; Senut et al., 1991), and corticocortical pathways
in the neocortex (Pearson et al., 1985; Rogers and
Morrison, 1985; Lewis et al., 1987; Hof and Morrison,
1990; Hof et al., 1990a,b; De Lacoste and White, 1993).
Specifically, it has been suggested that the distribu-
tion of NFTs and SPs is a reflection of the degeneration
of certain corticocortical connections and that the
dementia may progress along a defined set of projec-
tions, eventually leading to a syndrome of cortical
disconnection (Pearson et al., 1985; Rogers and Mor-
rison, 1985; Lewis et al., 1987; Hof et al., 1990a,b). In
fact, the laminar distribution of NFTs and SPs in areas
participating in hierarchically organized distributed
systems, such as the visual and auditory cortical path-
ways, reflects the origin and termination of cortico-
cortical projections as defined in connectivity studies
in nonhuman primate (Lewis et al., 1987; Hof et al.,
1990a; De Lacoste and White, 1993). In this context,
it is interesting that SP and NFT densities were not
systematically correlated in our geriatric patient pop-
ulation, even in anatomically linked regions within
the hippocampal formation. In fact, in agreement with
other authors (Arriagada et al., 1992b), amyloid de-
position seems to occur earlier in neocortical regions
than in the hippocampal formation, and shows no
correlation with the clinical diagnosis, or with NFT
formation locally as well as in distant anatomically
linked areas. This difference from previous observa-
tions on Alzheimer's disease cases may be due to the
fact that the present set of cases comprises only 10
clinically documented dementia cases, and that the
DMI and possibly some ND cases may represent early
stages in the dynamic processes leading to the end-
stage cortical patterns of NFTs and amyloid deposi-
tion that are fully recognizable only in severe Al-
zheimer's disease cases. Another pattern revealing
putative dynamic pathologic events is that NFTs ap-
pear first in layer III of the inferior temporal cortex
in our series, whereas in previous reports of severe
Alzheimer's disease cases, they were distributed in
both layers III and V with higher densities in layer V
(Lewis et al., 1987; Hof et al., 1990b), suggesting that
the supragranular layers might be involved in the de-
generative process earlier than the infragranular lay-
ers.
The analysis of this series of cases extends previous
observations on aging and Alzheimer's disease in that
it surveys a nonselected population of cases from a
nonpsychiatric institution. Globally, the finding that
all the cases display some degree of neuropatholog-
ical involvement of the medial regions of the temporal
lobe may be related to the fact that certain neurons
in these areas are usually affected early during aging
(Arriagada et al., 1992b; Vermersch et al., 1992; Vick-
ers et al., 1992). In particular, the allocortex and pa-
leocortical zones are damaged systematically in this
population, regardless of the clinical neurologic and
psychiatric status of the cases, whereas the neocortex
appears to be severely involved only at a time when
overt symptoms of dementia are present. In addition,
these findings stress the problem of the reliability of
neuropathologic rating scales for the diagnosis of Al-
zheimer's disease, and point to the fact that the pres-
ence of lesions in the hippocampal formation alone
is clearly insufficient to establish the diagnosis of de-
generative dementia, especially in patients present-
ing with mild cognitive impairment (Hofet al., 1992).
For instance, the involvement of the entorhinal cortex
and hippocampus proper in clinically nondemented
patients could represent the neuropathologic basis
for the age-associated memory impairment syndrome
(otherwise called benign senescent forgetfulness;
Crook et al., 1986; Gordon, 1992). These are middle-
aged as well as elderly patients presenting with no-
ticeable forgetfulness, whereas their daily function-
ing and judgement capabilities are not impaired. Such
correlations with early pathologic alterations and sub-
tle changes in cognitive abilities should, however,
been drawn with caution from the present data, since
our patients were assessed with a relatively poorly
sensitive instrument, although at least some of the
ND and DMI cases in the present analysis could fit
within this clinical definition. Interestingly, the NFT
distribution in these cases corresponds precisely to
the anatomic localization of neurons participating in
memory-related circuits (Hyman et al., 1986, 1988,
1990; Vickers et al., 1992). However, the involvement
of the hippocampal formation in the development of
dementia may account for a small part of the symp-
tomatology, but not for the massive intellectual de
cline and memory loss characteristic of patients with
severe Alzheimer's disease, which is more likely to
be correlated with the progressive damage of neo-
cortical areas. In this context, Terry and colleagues
have recently demonstrated a striking correlation be-
tween the degree of dementia and the loss of synapses
in several neocortical regions (Terry et al., 1991),
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indicating that dementia may be directly related to
the loss of specific connections between association
areas of the cerebral cortex.
The temporal separation of hippocampal and neo-
cortical degeneration may have important implica-
tions for diagnosis of an early decline in mental status
that may be a precursor to Alzheimer's disease, but
is still compatible with independent daily living. The
present data suggest that a significant proportion of
the aged population may be functioning at a high
level with substantial compromise of key hippocam-
pal circuits. It is therefore possible that memory is
highly dependent on hippocampal circuits at certain
processing stages, but may become quite indepen-
dent of the hippocampal formation, once addressing
and retrieval of information is dependent on neocor-
tical circuits (Hodges et al., 1992). In addition, the
present results indicate that sensitive neuropsycho-
logical assessment of the aged population should be
developed along two lines: first, memory assessment
that is primarily or completely dependent on intact
hippocampal circuits, and second, tests of visual func-
tion directed at processes such as complex form anal-
ysis that are dependent on the inferior temporal gyrus.
Sensitive neuropsychological tests designed with these
circuits in mind might detect deficits well in advance
of the cognitive decline that is linked to further neo-
cortical involvement. Should a mechanism become
available that slows down or halts the degenerative
process affecting corticocortical circuits beyond this
relatively limited portion of the temporal lobe, de-
tection of the early degenerative events will be es-
sential in order to initiate treatmentwhile the capacity
for independent living is still present.
Even though the distribution of NFT in aging ap-
pears to define select anatomic regions of the cerebral
cortex, the issue that many cellular variables may be
changing simultaneously in different cortical regions
remains to be addressed. The analysis of cellular pa-
thology in Alzheimer's disease revealed that only cer-
tain populations of neurons are prone to NFT for-
mation, and that specific morphologic and
neurochemical characteristics of the affected cells are
related to their heightened vulnerability. Recently, an
association has been demonstrated between the high
somatodendritic content in neurofilament protein of
specific neuron subgroups and their involvement in
NFT formation in the hippocampal formation and
neocortex in intellectually normal elderly people
(Vickers et al., 1992), as well as in Alzheimer's disease
cases (Morrison et al., 1987; Hof and Morrison, 1990;
Hof et al., 1990b). Conversely, other neuronal pop-
ulations, such as morphologically distinct classes of
interneurons that contain calcium-binding proteins,
are unaffected even in severe cases of Alzheimer's
disease (Hof and Morrison, 1991; Hof et al., 1991,
1993). This indicates that differential neuronal vul-
nerability in select elements of the cortical circuitry
may be a crucial factor in both the neuropathologic
changes observed in aging and in the progression of
Alzheimer's disease. In particular, normal aging has
been found associated with transitional cellular
changes in layer II of the entorhinal cortex consisting
of degenerating neurons labeled by antibodies to both
neurofilament protein and abnormally phosphorylat-
ed tau protein, whereas the prefrontal cortex in these
cases showed no such profile (Vickers et al., 1992).
Demented cases, however, contained end-stage NFTs
in the entorhinal cortex, which had lost their anti-
genic characteristics, while transitional forms were
present in the prefrontal cortex (Vickers et al., 1992).
This analysis and previous results also indicated that
NFTs are preferentially found by neurofilament pro-
tein-containing neurons and that a severe loss of neu-
rons without NFT formation is unlikely to occur, at
least at early stages of the dementing process (Hof et
al., 1990b; Vickers et al., 1992; Bouras et al., 1993).
These observations suggest that the cellular alter-
ations that occur in Alzheimer's disease represent a
dynamic and continuous process that affects different
cortical fields at different points in time, the hippo-
campal formation being apparently involved earlier
than the neocortex. Although the present results sug-
gest that the inferior temporal cortex may be the first
neocortical field to be affected by these cellular
changes, it has not yet been determined whether oth-
er cortical regions are simultaneously involved. In
addition, it should be mentioned that Alzheimer's
disease is not the only form of dementia that severely
affects the temporal cortex. For example, Pick's dis-
ease is also characterized by a massive involvement
of the temporal lobe (Brion et al., 1991). However, a
quantitative analysis of the neocortex in Pick's disease
cases has revealed that the laminar distribution of Pick
bodies involves small pyramidal neurons preferen-
tially located in layers II and VI, which are usually
not affected by NFT formation in Alzheimer's disease
(Hof et al., 1994). This differential cellular distribu-
tion of lesions may account for some of the clinical
differences observed between Pick's disease and Al-
zheimer's disease patients, as the neurons prone to
Pick body formation clearly subserve different sets of
cortical circuits. Thus, further studies of the molec-
ular and morphologic phenotype of specific neuronal
classes may allow for the definition of the key ele-
ments linked to their relative vulnerability in neu-
rodegenerative disorders and may help in developing
therapeutic strategies to protect the most sensitive
cells from the pathologic process.
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